DAY 1 -Stability Program Conference

We are delighted to announce IPA ‘s Stability Program Conference taking place on October 20-21, 2020 in Toronto Canada.

This interactive and comprehensive conference will provide attendees in learning how to establish the most effective, compliant, and improving your stability program from early stage development to commercial products. This includes latest regulatory compliance updates, scientific discoveries, technologies and innovations in the pharmaceutical, biopharmaceutical and allied industries.

Confirmed Speakers include:

Dr. Geoff Carr, Director, Analytical Development, Ontario, Patheon, by Thermo Fisher Scientific
Dr. Kristina Flavier, Sr. Scientist, FreeThink Technologies, Inc.
Christopher (Chris) V. Latoz , Stability Manager, Hollister Incorporated
Dr. Peter Tattersall, Senior Principal Scientist in Chemical and Synthetic Development within Pharmaceutical Development, Bristol-Myers Squibb Company
Emily S. D. Trubee, MS, Stability Manager, R&D, Adare Pharmaceuticals

And more to come!

Mark your calendar! Stay tuned for our full program details. To receive more information, please Click here.